Abstract:A central challenge in host-pathogen systems biology is the elucidation of general, systems-level principles that distinguish host-pathogen interactions from within-host interactions. Current analyses of host-pathogen and within-host protein-protein interaction networks are largely limited by their resolution, treating proteins as nodes and interactions as edges. Here, we construct a domain-resolved map of human-virus and within-human protein-protein interaction networks by annotating protein interactions with high-coverage, high-accuracy, domain-centric interaction mechanisms: (1) domain-domain interactions, in which a domain in one protein binds to a domain in a second protein, and (2) domain-motif interactions, in which a domain in one protein binds to a short, linear peptide motif in a second protein. Analysis of these domain-resolved networks reveals, for the first time, significant mechanistic differences between virus-human and within-human interactions at the resolution of single domains. While human proteins tend to compete with each other for domain binding sites by means of sequence similarity, viral proteins tend to compete with human proteins for domain binding sites in the absence of sequence similarity. Independent of their previously established preference for targeting human protein hubs, viral proteins also preferentially target human proteins containing linear motif-binding domains. Compared to human proteins, viral proteins participate in more domain-motif interactions, target more unique linear motif-binding domains per residue, and contain more unique linear motifs per residue. Together, these results suggest that viruses surmount genome size constraints by convergently evolving multiple short linear motifs in order to effectively mimic, hijack, and manipulate complex host processes for their survival. Our domain-resolved analyses reveal unique signatures of pleiotropy, economy, and convergent evolution in viral-host interactions that are otherwise hidden in the traditional binary network, highlighting the power and necessity of high-resolution approaches in host-pathogen systems biology.

Comprehensive characterization of human–virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs

Prediction and Analysis of Human-Herpes Simplex Virus Type 1 Protein-Protein Interactions by Integrating Multiple Methods

Human‐virus protein‐protein interactions maps assist in revealing the pathogenesis of viral infection

A network view of human immune system and virus-human interaction

Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities

Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

DeepViral: prediction of novel virus–host interactions from protein sequences and infectious disease phenotypes

The Domain Landscape of Virus-Host Interactomes.

Machine Learning Approaches for Predicting Virus-Human Protein-Protein Interactions: An Evaluation of Retroviral Interaction Networks

MVIP: multi-omics portal of viral infection

Network analysis and disease subnets for the SARS-CoV-2/Human interactome

Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective

Patterns of HIV-1 Protein Interaction Identify Perturbed Host-Cellular Subsystems

Signatures of Pleiotropy, Economy and Convergent Evolution in a Domain-Resolved Map of Human–Virus Protein–Protein Interaction Networks

Structure-based prediction of West Nile virus-human protein-protein interactions

Atlas of interactions between SARS-CoV-2 macromolecules and host proteins

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

Towards Understanding and Identification of Human Viral Co-Infections

Integrated Analysis of Human Influenza A (H1N1) Virus Infectionrelated Genes to Construct a Suitable Diagnostic Model

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing